SOURCE: Cypress Bioscience Inc.

Cypress Bioscience Inc.

June 16, 2009 06:30 ET

Cypress Bioscience, Inc. to Present at Jefferies 3rd Annual Healthcare Conference

SAN DIEGO, CA--(Marketwire - June 16, 2009) - Cypress Bioscience, Inc. (NASDAQ: CYPB) today announced that Sabrina Martucci Johnson, its Chief Operating Officer and Chief Financial Officer, will present at the Jefferies 3rd Annual Healthcare Conference on June 18, 2009.

The Jefferies conference is being held in New York, NY. Ms. Johnson is scheduled to present on Thursday, June 18th at 3:45 p.m. Eastern Time. The audio broadcast of this presentation can be accessed at

A replay of the presentation will be available at the same web address as well as on Cypress' website,

About Cypress Bioscience

Cypress Bioscience, Inc. provides therapeutics and personalized medicine services, facilitating improved and individualized patient care. Cypress addresses the evolving needs of specialist physicians and their patients by identifying unmet medical needs in the areas of pain, rheumatology, and physical medicine and rehabilitation, including challenging disorders such as fibromyalgia and rheumatoid arthritis. This approach to improving patient care creates a unique partnership with physicians. Current products include Savella™ (milnacipran HCI) and the Avise PG(SM) and Avise MCV(SM) therapeutic monitoring, diagnostic and prognostic tests for rheumatoid arthritis.

For more information about Cypress, please visit the Company's website at

Contact Information

  • For additional information please contact

    Mary Gieson
    Investor Relations
    (858) 452-2323
    Email Contact